Results 61 to 70 of about 925 (187)
Application of GPRC5D Targeting Therapy in Relapsed Refractory Multiple Myeloma
Cancer Medicine, Volume 14, Issue 6, March 2025.ABSTRACT Background As a rapidly developing therapeutic method, targeted therapy plays an important role in the treatment of multiple myeloma. In recent years, mature B cell antigen‐targeting therapy has brought new hope for patients with refractory/relapsed disease.
Sijia Yan +4 more
wiley +1 more source
Talquetamab in Multiple Myeloma: Efficacy, Safety, and Future Directions
European Journal of Haematology, Volume 114, Issue 3, Page 386-399, March 2025.ABSTRACT Relapsed and refractory multiple myeloma (RRMM) remains a challenging condition despite advances in immunotherapies. Novel bispecific antibodies (BsAbs), including talquetamab, have shown promising efficacy in heavily pretreated patients, even those with triple‐ and penta‐refractory disease.
Caterina Labanca +10 more
wiley +1 more source
Polymorphic Mucocutaneous Eruption and Septic Shock in a 75‐Year‐Old Man
JEADV Clinical Practice, Volume 5, Issue 1, Page 323-325, March 2026.
Sweta Subhadarshani +2 more
wiley +1 more source
Skin health of Aboriginal children living in urban communities
Australasian Journal of Dermatology, Volume 65, Issue 8, Page e224-e237, December 2024.Abstract Background Skin concerns are frequent among urban‐living Aboriginal children, yet specialist dermatology consultations are limited with studies highlighting the need for improved cultural security. Through newly established paediatric dermatology clinics at two urban Aboriginal Community Controlled Health Organisations (ACCHOs), we aimed to ...
Bernadette M. Ricciardo +13 more
wiley +1 more source
, 2016 DLA alleles in the Gordon setter (GS). Table S2. DLA alleles in the English setter (ES). Table S3. DLA haplotypes associated with symmetrical onychomadesis and protection for symmetrical onychomadesis in the Gordon setter. Table S4.
Stein Thoresen (3581168) +3 more
core +1 more source
LUTS: Lower Urinary Tract Symptoms, Volume 16, Issue 6, November 2024.ABSTRACT Objectives To evaluate the safety and effectiveness of vibegron, a highly selective β3‐adrenoceptor agonist, in Japanese patients with overactive bladder (OAB) in a real‐world clinical setting. Methods This prospective survey was conducted from August 2019 to July 2023 using a central registration method.
Shoko Yoshimura +3 more
wiley +1 more source
Enterovirus co-infections and onychomadesis after hand, foot, and mouth disease,Spain, 2008
Hand, foot, and mouth disease (HFMD), a common disease caused by enteroviruses (EVs), usually affects children. Clustered and sporadic HFMD cases, followed by onychomadesis (nail shedding), occurred during summer and fall 2008 in Valencia, Spain.
Córdoba, Juan +4 more
core +1 more source
Nail changes induced by chemotherapeutic agents
Indian Journal of Dermatology, 2020 Introduction: Nail toxicity is a relatively uncommon cutaneous adverse effect of chemotherapeutic agents. Rapidly dividing cells of the nail matrix are perturbed by the antimitotic activity of these agents. Although most of these changes are cosmetic and
Neerja Saraswat +4 more
doaj +1 more source
Health Science Reports, Volume 7, Issue 4, April 2024.Abstract Background and Aims Alopecia areata (AA) is an immune‐mediated nonscarring alopecia. Nail changes are a common disfiguring feature of AA with an average prevalence of 30%. We aimed to evaluate the frequency of different types of nail changes and determine demographic and clinical associations. Methods This cross‐sectional study included 197 AA
Safoura Shakoei +6 more
wiley +1 more source